// App-Quantinova.ai

FRI0165 : RISK OF CKD IN MEMBRANOUS AND PROLIFERATIVE LUPUS NEPHRITIS - ANALYSIS OF A NATIONWIDE MULTICENTRE COHORT

Researchers

Presenter

  • F. Farinha

Principal Investigators

  • S. C. Barreira

  • M. Couto

  • M. Cunha

  • D. Fonseca

  • R. Freitas

  • L. Ins

  • M. Luis

  • C. Macieira

  • A. R. Prata

  • J. Rodrigues

  • B. Santos

  • R. Pinheiro Torres

  • R. J. Pepper

  • A. Rahman

  • M. J. Santos

Medical Centers

  • Rheumatology, UCL, London, United Kingdom

  • HEM - CHLO, Rheumatology, Lisbon, Portugal

  • CHTV, Rheumatology, Viseu, Portugal

  • HGO, Rheumatology, Almada, Portugal

  • CHVNG/E, Rheumatology, VN Gaia, Portugal

  • CHUC, Rheumatology, Coimbra, Portugal

  • ULSAM, Rheumatology, Ponte de Lima, Portugal

  • CHBV, Rheumatology, Aveiro, Portugal

  • HEM - CHLO, Rheumatology, Lisbon, Portugal

  • UCL, Nephrology, London, United Kingdom

Locations

  • United Kingdom

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Lupus nephritis

Biomarkers

  • Cardiac phospholamban

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved